| Cancer type |
Cell line |
EpCAM antibody |
EpCAMaptamer |
| Pancreatic cancer |
PANC-1 |
++ |
++ |
| ASPC-1 |
++ |
++ |
| PANC-28 |
+ |
+ |
| Breast cancer |
MDA-MB-231 |
++ |
++ |
| MDA-MB-468 |
++ |
++ |
| BT-474 |
+ |
+ |
| SKBR3 |
++ |
++ |
| Ovarian cancer |
OVCAR3 |
+ |
+ |
| SKOV3 |
+ |
+ |
| Hey |
+ |
+ |
| Prostate cancer |
DU145 |
++ |
++ |
| 22RV1 |
+ |
+ |
| VCap |
+ |
+ |
| PC3 |
+ |
+ |
| Colon cancer |
HT29 |
++ |
++ |
| Epithelial cells |
293T |
++ |
++ |
| HeLa |
+ |
+ |
| Chronic myelogenous leukemia |
K562 |
++ |
++ |
| Burkitt’s lymphoma |
CA46 |
- |
- |
| Mantle Cell Lymphoma |
Jeko-1 |
- |
- |
| Mantle Cell Lymphoma |
Maver-1 |
- |
- |
| Acute Myeloid Leukemia |
HEL |
- |
- |
| Histiocytic lymphoma |
U937 |
- |
- |
|
| Note: “++” EpCAM overexpression, “+” EpCAM -positive,
“-” EpCAM-negative |
| Table 1: Summary of EpCAM aptamer binding to differentiate cancer
cells. |